Suppr超能文献

PHOSPHO1在基质小泡介导的骨骼矿化中的功能作用。

Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization.

作者信息

Roberts Scott, Narisawa Sonoko, Harmey Dympna, Millán José Luis, Farquharson Colin

机构信息

Bone Biology Group, Roslin Institute, Edinburgh, Scotland, UK.

出版信息

J Bone Miner Res. 2007 Apr;22(4):617-27. doi: 10.1359/jbmr.070108.

Abstract

UNLABELLED

PHOSPHO1 is a phosphatase highly expressed in bone. We studied its functional involvement in mineralization through the use of novel small molecule inhibitors. PHOSPHO1 expression was present within matrix vesicles, and inhibition of enzyme action caused a decrease in the ability of matrix vesicles to calcify.

INTRODUCTION

The novel phosphatase, PHOSPHO1, belongs to the haloacid dehalogenase superfamily of hydrolases and is capable of cleaving phosphoethanolamine (PEA) and phosphocholine to generate inorganic phosphate. Our aims in this study were to examine the expression of PHOSPHO1 in murine mineralizing cells and matrix vesicles (MV) and to screen a series of small-molecule PHOSPHO1-specific inhibitors for their ability to pharmacologically inhibit the first step of MV-mediated mineralization.

MATERIALS AND METHODS

q-PCR and immunohistochemistry were used to study the expression and localization profiles of PHOSPHO1. Inhibitors of PHOSPHO1's PEA hydrolase activity were discovered using high-throughput screening of commercially available chemical libraries. To asses the efficacy of these inhibitors to inhibit MV mineralization, MVs were isolated from TNAP-deficient (Akp2(-/-)) osteoblasts and induced to calcify in their presence.

RESULTS

q-PCR revealed a 120-fold higher level of PHOSPHO1 expression in bone compared with a range of soft tissues. The enzyme was immunolocalized to the early hypertrophic chondrocytes of the growth plate and to osteoblasts of trabecular surfaces and infilling primary osteons of cortical bone. Isolated MVs also contained PHOSPHO1. PEA hydrolase activity was observed in sonicated MVs from Akp2(-/-) osteoblasts but not intact MVs. Inhibitors to PHOSPHO1 were identified and characterized. Lansoprazole and SCH202676 inhibited the mineralization of MVs from Akp2(-/-) osteoblasts by 56.8% and 70.7%, respectively.

CONCLUSIONS

The results show that PHOSPHO1 localization is restricted to mineralizing regions of bone and growth plate and that the enzyme present within MVs is in an active state, inhibition of which decreases the capacity of MVs to mineralize. These data further support our hypothesis that PHOSPHO1 plays a role in the initiation of matrix mineralization.

摘要

未标记

PHOSPHO1是一种在骨中高表达的磷酸酶。我们通过使用新型小分子抑制剂研究了其在矿化过程中的功能作用。PHOSPHO1表达存在于基质小泡中,抑制酶的作用会导致基质小泡钙化能力下降。

引言

新型磷酸酶PHOSPHO1属于水解酶的卤代酸脱卤酶超家族,能够裂解磷酸乙醇胺(PEA)和磷酸胆碱以生成无机磷酸盐。我们在本研究中的目的是检测PHOSPHO1在小鼠矿化细胞和基质小泡(MV)中的表达,并筛选一系列小分子PHOSPHO1特异性抑制剂,以评估其在药理上抑制MV介导矿化第一步的能力。

材料与方法

采用q-PCR和免疫组织化学方法研究PHOSPHO1的表达和定位情况。通过对市售化学文库进行高通量筛选,发现了PHOSPHO1的PEA水解酶活性抑制剂。为评估这些抑制剂抑制MV矿化的效果,从组织非特异性碱性磷酸酶缺陷(Akp2(-/-))的成骨细胞中分离出MV,并在有抑制剂存在的情况下诱导其钙化。

结果

q-PCR显示,与一系列软组织相比,骨中PHOSPHO1的表达水平高120倍。该酶免疫定位在生长板的早期肥大软骨细胞以及小梁表面的成骨细胞和皮质骨填充的初级骨单位中。分离出的MV中也含有PHOSPHO1。在来自Akp2(-/-)成骨细胞的超声处理的MV中观察到PEA水解酶活性,但完整的MV中未观察到。鉴定并表征了PHOSPHO1的抑制剂。兰索拉唑和SCH202676分别抑制来自Akp2(-/-)成骨细胞的MV矿化56.8%和70.7%。

结论

结果表明,PHOSPHO1的定位仅限于骨和生长板的矿化区域,并且MV中存在的该酶处于活性状态,抑制其活性会降低MV的矿化能力。这些数据进一步支持了我们的假设,即PHOSPHO1在基质矿化的起始过程中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验